Petersén A, Mani K, Brundin P
Department of Physiological Sciences, Wallenberg Neuroscience Center, Sölvegatan 17, Lund, 222 52, Sweden.
Exp Neurol. 1999 May;157(1):1-18. doi: 10.1006/exnr.1998.7006.
We review recent advances regarding the pathogenesis of Huntington's disease (HD). This genetic neurodegenerative disorder is caused by an expanded CAG repeat in a gene coding for a protein, with unknown function, called huntingtin. There is selective death of striatal and cortical neurons. Both in patients and a transgenic mouse model of the disease, neuronal intranuclear inclusions, immunoreactive for huntingtin and ubiquitin, develop. Huntingtin interacts with the proteins GAPDH, HAP-1, HIP1, HIP2, and calmodulin, and a mutant huntingtin is specifically cleaved by the proapoptotic enzyme caspase 3. The pathogenetic mechanism is not known, but it is presumed that there is a toxic gain of function of the mutant huntingtin. Circumstantial evidence suggests that excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis play a role.
我们回顾了关于亨廷顿舞蹈病(HD)发病机制的近期进展。这种遗传性神经退行性疾病是由一个编码名为亨廷顿蛋白(功能未知)的基因中的CAG重复序列扩增所引起的。纹状体和皮质神经元会出现选择性死亡。在该病患者以及转基因小鼠模型中,均会形成对亨廷顿蛋白和泛素呈免疫反应性的神经元核内包涵体。亨廷顿蛋白与甘油醛-3-磷酸脱氢酶、亨廷顿相互作用蛋白1、亨廷顿相互作用蛋白2、亨廷顿相互作用蛋白3以及钙调蛋白相互作用,并且突变型亨廷顿蛋白会被促凋亡酶半胱天冬酶3特异性切割。发病机制尚不清楚,但据推测突变型亨廷顿蛋白存在功能获得性毒性。间接证据表明兴奋性毒性、氧化应激、能量代谢受损以及细胞凋亡都发挥了作用。